FAKTOR-OPTIONSSCHEIN - QUEST DIAGNOSTICS | Real-time Bid/Ask 15:58:31 24/05/2024 BST | ||
| 8.51 EUR / 8.59 EUR | +0.35% |
|
| Current month | -8.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24/05/24 | 8.58 | +0.70% |
| 23/05/24 | 8.52 | +3.02% |
| 22/05/24 | 8.27 | +5.08% |
| 21/05/24 | 7.87 | +1.55% |
| 20/05/24 | 7.75 | +0.39% |
Delayed Quote Börse Stuttgart
Last update May 24, 2024 at 01:53 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | MG34Y7 |
| ISIN | DE000MG34Y75 |
| Date issued | 26/04/2024 |
| Strike | 177.3 $ |
| Maturity | Unlimited |
| Parity | 3.99 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.61 € |
|---|---|
| Lowest since issue | 7.47 € |
| Spread | 0.05 € |
| Spread % | 0.59% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
140
USD
Average target price
146.8
USD
Spread / Average Target
+4.83%
- Stock Market
- Certificates
- Certificat
